Navigation Links
Obama Acts to Ease U.S. Drug Shortages
Date:10/31/2011

By Amanda Gardner
HealthDay Reporter

MONDAY, Oct. 31 (HealthDay News) -- Jay Cuetara arrived at the chemotherapy suite of his hospital one day and was told a critical component of the chemo cocktail that had kept his metastatic cancer in check for two-and-a-half years was unavailable.

Cuetara, 49, didn't get treatment that day, but he still was one of the lucky ones: His San Francisco hospital managed to procure the drug and he resumed treatment in just one week. Others have been less fortunate.

Now, an executive order signed by President Barack Obama Monday may help ease the drug shortages that threaten the lives of patients like Cuetara across the United States.

The executive order directs the U.S. Food and Drug Administration (FDA) to "take action" to prevent and reduce the worsening prescription drug shortages that have plagued the country for several years.

"Between 2005 and 2010, the number of prescription drug shortages has tripled," said Kathleen Sebelius, secretary of the U.S. Department of Health and Human Services, at a Monday news conference.

So far this year, some 200 drug shortages have occurred compared to 178 in all of 2010, the FDA previously stated.

The executive order directs the FDA to take steps to require drug manufacturers to report any impending shortages or discontinuances six months ahead of the shortage, as recommended by pending bipartisan legislation.

Now, drug manufacturers only have a legal obligation to notify the FDA if they are discontinuing a drug for which there is just one manufacturer, FDA commissioner Dr. Margaret Hamburg said, speaking at the news conference. Other notifications are voluntary.

"The data is clear that early notification has a significant and meaningful impact on drug shortage," said Hamburg.

The FDA should also speed up its review of new manufacturing sites, new suppliers and new manufacturing protocols, and also add more staff to its drug-shortage office, the order stated.

The order also calls on the FDA to work with the U.S. Department of Justice to see if "gray market profiteers are hoarding drugs and charging exorbitant prices," said Sebelius.

"In past months we've heard of blood pressure drugs which are normally sold for $26 being sold for $1,200," she said.

Experts said the executive order is a good start, but that more is needed.

"This is a step in the right direction, but there's still much more to be done," said Dr. J. Leonard Lichtenfeld, deputy chief medical officer of the American Cancer Society. "We think the shortage issue is very serious. It's a major issue and it's disrupting patient care."

Another expert agreed. "I think this will help . . . [but] I still think there are some fundamental contributing factors that eventually will have to be addressed," added Dr. James Speyer, medical director of the Clinical Cancer Center at NYU Langone Medical Center in New York City.

Many of the scarce drugs are injectables, such as cytarabine and cisplatin, used to treat serious conditions such as cancer.

And most of the drugs are generic, meaning companies don't make much money on them and may, in some cases, opt to discontinue them.

The shortages occur frequently because of manufacturing problems, ranging from contamination to late delivery of raw materials. Other difficulties include label and packaging misprints and increased demand.

Some people believe FDA practices contribute to the shortages. For instance, critics say that if a plant is closed because of contamination, the FDA needs to speed up inspection of the facility to allow them to start producing the drug again.

More information

For more information on drug shortages, visit the U.S. Food and Drug Administration.

SOURCES: J. Leonard Lichtenfeld, M.D., deputy chief medical officer, American Cancer Society; James Speyer, M.D., medical director, Clinical Cancer Center, NYU Langone Medical Center, New York City; Oct. 31, 2011, teleconference with Kathleen Sebelius, Secretary, U.S. Department of Health and Human Services; Margaret Hamburg, M.D., commissioner, U.S. Food and Drug Administration; Jay Cuetara, patient, San Francisco


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. President Barack Obama recognizes outstanding scientists at the Smithsonian
2. AADR applauds President Obamas support for maintaining biomedical research in FY11
3. ACP applauds President Obamas call for state innovation on health insurance coverage
4. First Lady Says President Obama Has Quit Smoking
5. Obama to Sign Bill to Improve U.S. Food Safety
6. Obama to Appeal Stem Cell Ruling
7. President Obama Must Investigate Reports of Detainee Abuse at Bagram Air Base
8. Top DTC Marketers Choose Obama Over Romney and Palin
9. Over 10,000 Americans Join Lawsuit Against Obamacare
10. Health Reform For Doctors And Hospitals: Obama Made An Offer We Can't Refuse! - ERISAclaim.com Celebrates its Successful Webinars on Reimbursement Laws
11. New Free Webinars Announced to Discuss the Latest Federal Court Overpayment Lawsuit Ruling and New Obama Health Laws for the Skyrocketing $6 Trillion Overpayment Recoupment Market
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Obama Acts to Ease U.S. Drug Shortages 
(Date:1/23/2017)... ... January 23, 2017 , ... ... Living (IHCA/INCAL), will serve as a healthcare industry expert at the 2017 Sector ... discussion, moderated by Inside Indiana Business host Gerry Dick, will feature an employer ...
(Date:1/23/2017)... Greifensee, Switzerland (PRWEB) , ... January 23, 2017 ... ... many lab and production applications. However, choosing the right method is paramount to ... may occur more often in situations where multiple persons use the same equipment. ...
(Date:1/23/2017)... ... 23, 2017 , ... "ProRandom is a set of camera tools that allow video editors to ... Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. , With ... with video footage. ProRandom works by using a virtual camera to create the illusion ...
(Date:1/23/2017)... (PRWEB) , ... January 23, ... ... Education Foundation (OREF), in partnership with the American Society of Anesthesiologists® (ASA®), ... Foundation (APSF), the American Academy of Orthopaedic Surgeons (AAOS) and the Cigna ...
(Date:1/23/2017)... , ... January 23, 2017 , ... “The Inn at the Mill”: a story ... fears in her quest to become happy and content. , “The Inn at the ... has also lived in Germany and Vermont and is now living in Berks County on ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... January 23, 2017 Ahead of today,s trading ... how they have fared at the close: Kite Pharma Inc. (NASDAQ: ... OVAS ), and Regeneron Pharmaceuticals Inc. (NASDAQ: ... were relative laggards on Friday, January 20 th , 2017, down ... research reports on these stocks now at: ...
(Date:1/23/2017)... , January 23, 2017 A new ... Testing Market was valued at US$0.53 bn in 2013 and ... a strong 17.50% CAGR between 2014 and 2022. The title of ... Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 - 2022." ... Non-invasive prenatal testing ...
(Date:1/23/2017)... The global  anxiety disorders and depression treatment market  is expected to reach ... worldwide is anticipated to drive the market growth in the coming years. Increasing ... in the recent years. Continue Reading ... ... ...
Breaking Medicine Technology: